Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Morepen Laboratories Ltd Financial Statements & Historical Data

Updated NSE: MOREPENLABBSE: 500288
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 5 October 2026, 9:19 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price135₹ per share
Reported P/E63.2Times
Book value per share22.8₹ per share
Reported ROCE8.05 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 5 October 2026, 9:19 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap7,414 Cr.
Current Price135
High / Low138/33.0
Stock P/E63.2
Book Value22.8
Dividend Yield0.15 %
ROCE8.05 %
ROE5.33 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Morepen Laboratories Ltd 7,414 Cr. 135 138/33.063.2 22.80.15 %8.05 %5.33 % 2.00
Entero Healthcare Solutions Ltd 7,315 Cr. 1,681 1,920/94456.7 3880.00 %10.5 %6.94 % 10.0
Bliss GVS Pharma Ltd 7,063 Cr. 665 745/11851.3 1130.23 %16.9 %11.8 % 1.00
Sanofi India Ltd 6,978 Cr. 3,024 4,898/3,00020.4 3592.48 %57.5 %43.0 % 10.0
Aarti Pharmalabs Ltd 8,603 Cr. 947 1,002/58440.0 2340.37 %10.7 %8.59 % 5.00
Industry Average17,430.58 Cr1,241.4354.21211.240.39%26.16%16.59%6.06

All Competitor Stocks of Morepen Laboratories Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 401422445423455438453466425412484485570
Expenses 375388394375404394417424401381438460488
Operating Profit 26345148524436422431462483
OPM % 7%8%11%11%11%10%8%9%6%7%10%5%14%
Other Income 23443555430485
Interest 0021111544445
Depreciation 88810625169111068
Profit before tax 21294442484635261646352375
Tax % 29%26%27%32%25%24%24%21%26%10%22%33%24%
Net Profit 15213229363527201141281656
EPS in Rs 0.290.420.630.550.710.640.490.370.200.750.500.291.03

Last Updated: September 29, 2026, 6:56 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 4, 2026, 9:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3674014855956077698531,1881,5471,4181,6901,8121,8061,951
Expenses 3183524245345427017851,0701,4101,3381,5321,6381,6801,767
Operating Profit 4948626165686911913780159174126184
OPM % 13%12%13%10%11%9%8%10%9%6%9%10%7%9%
Other Income 41-344491210614184748
Interest 1091084222-72481617
Depreciation 4639353434403730282833293636
Profit before tax -3213243029399912756135155120179
Tax % 0%6%-1%0%0%1%14%1%20%31%29%24%20%
Net Profit -32132430293497102399711896141
EPS in Rs -0.060.050.280.530.660.640.752.162.130.761.882.151.732.57
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%9%12%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)166.67%550.00%84.62%25.00%-3.33%17.24%185.29%5.15%-61.76%148.72%21.65%-18.64%
Change in YoY Net Profit Growth (%)0.00%383.33%-465.38%-59.62%-28.33%20.57%168.05%-180.14%-66.92%210.48%-127.07%-40.29%

Morepen Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

No data available for the compounded sales growth chart.

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 4, 2026, 9:16 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 9090909090909096102102110110
Reserves 78911061361631943354836517451,0471,137
Borrowings 20118716913413213317192529105208
Other Liabilities 121156173226230246416473332417517482
Total Liabilities 4895245385866156638581,0701,1101,2931,7781,936
Fixed Assets 322297272264236216225252267307489513
CWIP 00000021417242822
Investments 000001100185124
Other Assets 1672272663213794466318048279601,1761,277
Total Assets 4895245385866156638581,0701,1101,2931,7781,936
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 51504163171151-60-91733233
Cash from Investing Activity + -32-27-14-27-13-12-70-32-47-83-322-126
Cash from Financing Activity + -19-27-24-38-054766144530097
Net Cash Flow -0-43-14428-266-5104
Free Cash Flow 464131376-610-127-137-8-182-127
CFO/OP 105%81%66%98%26%25%44%-26%-94%70%40%46%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow46.0041.0031.0037.006.00-6.0010.00-127.00-137.00-8.00-182.00-127.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 425166577364595659687065
Inventory Days 565551657669918296878594
Days Payable 116126140125173124113989087101114
Cash Conversion Cycle -17-20-23-3-249374065695445
Working Capital Days -21-20-10-86-62-34-817559894107
ROCE %1%3%8%9%9%8%10%23%23%8%17%15%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 38.22%38.22%38.22%38.22%35.66%35.66%35.66%35.66%35.66%35.66%35.66%35.66%
FIIs 1.29%2.11%1.85%1.67%2.08%2.22%1.94%1.72%1.62%1.62%1.59%1.46%
DIIs 2.27%2.21%2.15%2.14%1.69%1.64%1.67%1.50%1.49%1.25%1.25%1.28%
Government 0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Public 58.20%57.46%57.76%57.96%60.57%60.46%60.72%61.09%61.22%61.46%61.50%61.59%
No. of Shareholders 3,04,0013,04,2893,36,0193,48,7664,30,9294,48,3614,68,8604,61,1804,61,8534,53,1374,47,2864,34,912
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal BSE Healthcare ETF 4,401 0.16 0.024,4012025-04-22 16:00:160%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 2.201.880.772.262.16
Diluted EPS (Rs.) 2.201.880.771.962.16
Cash EPS (Rs.) 2.682.541.302.712.83
Book Value[Excl.RevalReserv]/Share (Rs.) 21.1016.5814.7212.109.43
Book Value[Incl.RevalReserv]/Share (Rs.) 21.1016.5814.7212.109.43
Revenue From Operations / Share (Rs.) 33.0633.0727.7332.3726.41
PBDIT / Share (Rs.) 3.513.381.683.082.90
PBIT / Share (Rs.) 2.982.721.132.502.23
PBT / Share (Rs.) 2.832.651.092.652.19
Net Profit / Share (Rs.) 2.151.890.752.132.16
NP After MI And SOA / Share (Rs.) 2.151.880.752.132.16
PBDIT Margin (%) 10.6210.216.049.5010.99
PBIT Margin (%) 9.028.234.077.718.44
PBT Margin (%) 8.568.013.938.198.29
Net Profit Margin (%) 6.515.712.726.578.17
NP After MI And SOA Margin (%) 6.515.682.726.578.17
Return on Networth / Equity (%) 10.2011.345.1317.5722.85
Return on Capital Employeed (%) 12.7915.617.3119.4422.07
Return On Assets (%) 6.637.433.489.5011.31
Long Term Debt / Equity (X) 0.020.000.000.000.00
Total Debt / Equity (X) 0.060.030.030.030.03
Asset Turnover Ratio (%) 1.181.411.301.601.47
Current Ratio (X) 2.322.212.351.611.30
Quick Ratio (X) 1.721.591.641.000.87
Inventory Turnover Ratio (X) 6.603.703.103.534.01
Interest Coverage Ratio (X) 23.0746.5243.25-19.9673.02
Interest Coverage Ratio (Post Tax) (X) 15.1527.0420.53-12.8155.29
Enterprise Value (Cr.) 2682.562126.721280.991720.861393.88
EV / Net Operating Revenue (X) 1.481.260.901.111.17
EV / EBITDA (X) 13.9412.3214.9511.7110.67
MarketCap / Net Operating Revenue (X) 1.451.270.921.131.22
Price / BV (X) 2.272.541.743.023.40
Price / Net Operating Revenue (X) 1.451.270.921.131.22
EarningsYield 0.040.040.020.050.06
Advertisements
Explore Industry-wise Company financial data